Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies.

scientific article published on 4 November 2011

Validation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/1479164111424762
P698PubMed publication ID22058089

P50authorTorben JørgensenQ7825461
Leif GroopQ27214742
Torben HansenQ29583803
Oluf Borbye PedersenQ29583849
P2093author name stringKnut Borch-Johnsen
Valeria Lyssenko
Janice Kolberg
Michael P McKenna
Robert W Gerwien
Michael W Rowe
P2860cites workClinical risk factors, DNA variants, and the development of type 2 diabetesQ34884389
Predictors of progression from impaired glucose tolerance to NIDDM: an analysis of six prospective studiesQ36839519
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitusQ37141727
Development of a type 2 diabetes risk model from a panel of serum biomarkers from the Inter99 cohortQ37235925
Validation of a multimarker model for assessing risk of type 2 diabetes from a five-year prospective study of 6784 Danish people (Inter99).Q37404546
Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?Q43960351
An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetesQ44040130
Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic womenQ44114894
The diabetes risk score: a practical tool to predict type 2 diabetes riskQ44333486
A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.Q44685218
Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetesQ45199153
Two risk-scoring systems for predicting incident diabetes mellitus in U.S. adults age 45 to 64 years.Q45987114
Cost-effectiveness of screening for pre-diabetes among overweight and obese U.S. adults.Q51465708
Short-term variability in measures of glycemia and implications for the classification of diabetes.Q51467211
Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study.Q51470643
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminQ22250892
Progression from newly acquired impaired fasting glusose to type 2 diabetesQ24683882
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose toleranceQ28186874
The meaning and use of the area under a receiver operating characteristic (ROC) curveQ29547182
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyondQ29614697
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approachQ29614698
Report of the Expert Committee on the Diagnosis and Classification of Diabetes MellitusQ29616284
Implications of alternative definitions of prediabetes for prevalence in U.S. adultsQ34507171
P433issue1
P407language of work or nameEnglishQ1860
P921main subjecttype 2 diabetesQ3025883
P304page(s)59-67
P577publication date2011-11-04
P1433published inDiabetes and Vascular Disease ResearchQ5270121
P1476titleValidation of a multi-marker model for the prediction of incident type 2 diabetes mellitus: combined results of the Inter99 and Botnia studies.
P478volume9

Reverse relations

cites work (P2860)
Q38009358'Omics'-driven discoveries in prevention and treatment of type 2 diabetes
Q91945035A Review of Recent Evidence from Meal-Based Diet Interventions and Clinical Biomarkers for Improvement of Glucose Regulation
Q38596433An exploratory retrospective assessment of a quantitative measure of diabetes risk: medical management and patient impact in a primary care setting
Q35581227Biomarker models as surrogates for the disposition index in the Insulin Resistance Atherosclerosis Study
Q57012108Genomic, Transcriptomic, and Lipidomic Profiling Highlights the Role of Inflammation in Individuals With Low High-density Lipoprotein Cholesterol
Q41634378Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solution
Q38404230Performance of a multi-marker diabetes risk score in the Insulin Resistance Atherosclerosis Study (IRAS), a multi-ethnic US cohort
Q49438496Plasma adiponectin levels and type 2 diabetes risk: a nested case-control study in a Chinese population and an updated meta-analysis
Q35189544Poorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnostics
Q56974269Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells
Q38146916The potential of novel biomarkers to improve risk prediction of type 2 diabetes
Q35229122The potential use of DNA methylation biomarkers to identify risk and progression of type 2 diabetes